Overview
CMPS market data
Price History
CMPS price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$3.08 Diluted earnings per share over the trailing twelve months.
- Beta
- 2.55 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $3.92 – $15.40 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $1.6K · P/B 1.67.
Company news
Why Is Robinhood Stock Falling on Thursday?Benzinga · Jul 23, 2026, 5:44 PM
Cathie Wood Swaps Robinhood for SpaceX, Archer—Did ARK Pivot Back to Moonshot Innovation?Benzinga · Jul 23, 2026, 4:10 PM
Why Is Neuronetics Stock Soaring Monday?Benzinga · Jul 20, 2026, 6:21 PM
Why Is GH Research Stock Trading Higher on Thursday?Benzinga · Jul 16, 2026, 4:36 PM
Compass Pathways shares are trading higher after the company announced the publication of a post-hoc analysis of support methods used in an open-label Phase 2 study of investigational COMP360 synthetic psilocybin treatment in patients with post-traumatic stress disorder.Benzinga · Jul 16, 2026, 1:00 PM
Compass Pathways Announces Publication Of Post-Hoc Analysis Of Support Methods In Phase 2 Study Of Investigational COMP360 Synthetic Psilocybin TreatmentBenzinga · Jul 16, 2026, 10:37 AM
Why JB Hunt Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving PremarketBenzinga · Jul 16, 2026, 8:26 AM
HC Wainwright & Co. Reiterates Buy on Compass Pathways, Maintains $70 Price TargetBenzinga · Jul 8, 2026, 4:40 PM
Evercore ISI Group Upgrades Compass Pathways to Outperform, Raises Price Target to $21Benzinga · Jul 8, 2026, 2:50 PM
Stifel Maintains Buy on Compass Pathways, Raises Price Target to $21Benzinga · Jul 8, 2026, 1:30 PM